戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1                   Therefore, B7RP-1 exhibits co-stimulatory activities in vitro and in vivo.
2           LIGHT has potent, CD28-independent co-stimulatory activity leading to T-cell growth and sec
3  self-antigens involves a complex network of co-stimulatory and co-inhibitory molecules.
4 In this review, we will focus on the role of co-stimulatory and co-inhibitory pathways in two systemi
5 major component of which is a large array of co-stimulatory and co-inhibitory pathways that modulate
6  critically impacted by the constellation of co-stimulatory and co-inhibitory receptors expressed on
7  these superfamilies but potentially between co-stimulatory and co-inhibitory receptors.
8 revealed coexpression of multiple additional co-stimulatory and co-inhibitory receptors.
9               Signals transmitted by T cell, co-stimulatory and cytokine receptors control Thp lineag
10  function and the dynamic integration of the co-stimulatory and T-cell receptor signals are just begi
11                                          The co-stimulatory antigen CD28 has been shown to bind to se
12 of high-dose bone marrow transplantation and co-stimulatory blockade can thus achieve allogeneic bone
13                                              Co-stimulatory blockade has been shown to prolong allogr
14 als conditioned with anti-CD4, anti-CD8, and co-stimulatory blockade in addition to lethal irradiatio
15  transfusion (DST) can synergize with T cell co-stimulatory blockade in inducing tolerance in several
16 ction and Tg graft loss following CD40:CD40L co-stimulatory blockade in this model provides opportuni
17 een shown to overcome tolerance induction by co-stimulatory blockade or regulatory T cells.
18 -alpha responses and impaired the ability of co-stimulatory blockade to extend allograft survival.
19 alpha in the graft recipient synergized with co-stimulatory blockade to induce tolerance.
20                        Unexpectedly, though, co-stimulatory blockade with anti-CD154 or CTLA4-Ig indu
21 ects and with tolerogenic potential, such as co-stimulatory blockade, would be a great improvement if
22                                 Abatacept, a co-stimulatory blocker, and rituximab, a B cell depletin
23 cell antigen receptor and, thus, function as co-stimulatory, but not direct stimulatory, molecules.
24 e crystal structure of the human CTLA-4/B7-1 co-stimulatory complex at 3.0 A resolution.
25 s are amplified by coligation of BCR and the co-stimulatory complex, and several self Ags targeted in
26 amplification of STAT3 phosphorylation under co-stimulatory conditions.
27 tion pathway can impact greatly not only the co-stimulatory context in which the antigen is presented
28 xtensive clinical use, the attributes of CAR co-stimulatory domains that impact persistence and resis
29                           Here is reported a co-stimulatory effect of angiotensin II (AngII) by showi
30                           B7-1 is one of the co-stimulatory factors which plays an important role in
31 gs support a substantially revised model for co-stimulatory function in the primary GC response, with
32 acking isoforms, which may down-regulate the co-stimulatory function of dectin-1.
33  T cells and macrophages can be altered with co-stimulatory inhibitors, but may not be a significant
34 -4, is an important mediator of adhesive and co-stimulatory interactions that govern cutaneous immune
35  cytokines but partially dependent on direct co-stimulatory interactions via ICOSL-ICOS.
36 rapeutic interventions targeting ICOS.ICOS-L co-stimulatory interactions.
37  around the concept that CD86 is the initial co-stimulatory ligand based on its more abundant and ear
38        Recent studies identified ICAM-1 as a co-stimulatory ligand that binds to lymphocyte function
39 nflammatory mediator release is modulated by co-stimulatory ligands (CD80 and CD86) expressed by the
40 Neither cell population was positive for the co-stimulatory markers CD40, CD80 and CD86, but both dem
41 promoted BMDC maturation and upregulation of co-stimulatory markers, including CD40, CD86, and MHC-II
42                     In particular, targeting co-stimulatory members of the tumor necrosis factor rece
43 drugs in development are those targeting the co-stimulatory modulation, cytokines and the B and T cel
44               Interactions between inducible co-stimulatory molecule (ICOS) and ICOS-ligand (ICOS-L)
45                                The inducible co-stimulatory molecule (ICOS) is a CD28 homologue impli
46                                The inducible co-stimulatory molecule (ICOS), a third member of the CD
47 y (Treg) cells with high levels of inducible co-stimulatory molecule (ICOS).
48 ation of MHC class I and II antigens and the co-stimulatory molecule B7 suggests increased immunogeni
49 6 and IL-8, as well as the expression of the co-stimulatory molecule B7.1, which is required for the
50 eD-dependent depletion of surface MHCII, the co-stimulatory molecule B7.2, and suppression of T cell
51 face receptor Slamf1 functions not only as a co-stimulatory molecule but also as a microbial sensor o
52                                          The co-stimulatory molecule CD28 is essential for activation
53 on signals delivered through the TCR and the co-stimulatory molecule CD28.
54   IL-36alpha increased the expression of the co-stimulatory molecule CD40 and enhanced the ability of
55  production, showed robust expression of the co-stimulatory molecule CD40L, and promoted the developm
56  the role of complement regulator and T cell co-stimulatory molecule CD46, and also discussed are cha
57 ed significantly higher MHC class II and the co-stimulatory molecule CD80 compared to Tetherin KO DCs
58 henotypically mature as they up-regulate the co-stimulatory molecule CD86 from intracellular storages
59 otein ligand (GITRL) is a recently described co-stimulatory molecule expressed by antigen-presenting
60                                              Co-stimulatory molecule expression (CD40, 80, 86, and I-
61  assessed by cytokine production (ELISA) and co-stimulatory molecule expression (flow cytometry).
62            We demonstrate that the increased co-stimulatory molecule expression (MHC II and CD86) and
63 transplantation to study the role of MHC and co-stimulatory molecule expression on DST cells in media
64  no interleukin (IL)-12p35 mRNA, low surface co-stimulatory molecule expression, and CCR transcripts,
65 ntigen presentation through up-regulation of co-stimulatory molecule expression, and promote survival
66            Loss of Nrf2 results in increased co-stimulatory molecule expression, enhanced T cell stim
67 n (PSA) and containing transgenes for T-cell co-stimulatory molecule expression, including CD80.
68 ficantly inhibit BMDC maturation by reducing co-stimulatory molecule expression.
69  allele diminishes the expression of CD40, a co-stimulatory molecule for T cell polarization.
70 tein ligand (GITRL), a ligand for the T cell co-stimulatory molecule GITR, is expressed by keratinocy
71 To investigate the roles of B7-1 and/or B7-2 co-stimulatory molecule in the development of graft arte
72                  The clustering state of the co-stimulatory molecule lymphocyte function-associated a
73                                    CD27 is a co-stimulatory molecule of T cells, and inherited CD27 d
74  up-regulated the expression of the negative co-stimulatory molecule PD-L1, and this can be prevented
75 Our studies thus define a previously unknown co-stimulatory molecule that may be involved in the nega
76 , detected by NLDC-145 antibody and the CD80 co-stimulatory molecule, as well as Ia antigen on exposu
77                                          The co-stimulatory molecule, CD86, which is critical for DC/
78 h its cellular receptor 1 (HAVCR1), a T-cell co-stimulatory molecule, inhibits the function of Treg c
79 lpha4beta1 (CD49d) which, as well as being a co-stimulatory molecule, is required for CLL cells to un
80 press GITRL, and that through this important co-stimulatory molecule, they have the potential to infl
81 s major histocompatibility complex (MHC) and co-stimulatory molecules and are recognized and killed b
82 ed into chemokine-producing DCs that express co-stimulatory molecules and can prime naive T cells.
83               Signals from T-cell receptors, co-stimulatory molecules and cytokine receptors direct t
84 immune response depends on the expression of co-stimulatory molecules and cytokines by antigen-presen
85 y, the improved understanding of the role of co-stimulatory molecules and cytokines IL-10 and IL-2 in
86 rrelation, DCs up-regulate the expression of co-stimulatory molecules and cytokines.
87 intrinsic effect leading to up-regulation of co-stimulatory molecules and subsequent T cell activatio
88 10, which in turn can downregulate important co-stimulatory molecules and the cytokines IL-12 and IFN
89 rd, activation of TLRs induces expression of co-stimulatory molecules and the release of cytokines th
90 ibodies and fusion proteins targeting T-cell co-stimulatory molecules are now in late-stage clinical
91 quire surface expression of MHC class II and co-stimulatory molecules as well as T-cell stimulatory a
92      The induction of CTL effectors requires co-stimulatory molecules B7-1 and/or B7-2 on host antige
93 MHC-II+ macrophages and cells expressing the co-stimulatory molecules B7-2 and CD40, as well as IgM +
94 cells, we investigated the expression of the co-stimulatory molecules BB-1, B7-1 (CD80) B7-2 (CD86) a
95 5(+) cells with reduced up-regulation of the co-stimulatory molecules CD80, CD86, and CD68.
96        Blocking CD28, CD154 (CD40L), or both co-stimulatory molecules has been efficacious in prevent
97 potently induced expression of cytokines and co-stimulatory molecules HLA-DR and CD86 in human newbor
98 recently strengthened by the upregulation of co-stimulatory molecules ICOS/ICOS-L and PD-L1.
99 n terms of up-regulation of MHC class II and co-stimulatory molecules in the absence and presence of
100 gs indicate distinct roles for B7-1 and B7-2 co-stimulatory molecules in the development of GAD, pote
101 ocytosis is downregulated, the expression of co-stimulatory molecules is enhanced, and newly formed i
102 ajor histocompatibility complex class II and co-stimulatory molecules on antigen-presenting cells (AP
103                           The interaction of co-stimulatory molecules on T cells with B7 molecules on
104     We also analyzed expression of different co-stimulatory molecules on virus-specific CD8+ and fork
105 expressed significantly higher levels of the co-stimulatory molecules OX40 (37.2% of FOXP3+ cell popu
106                                          The co-stimulatory molecules SLAMF3 and SLAMF6 have been imp
107 n several pathways of regulation of ILC2s by co-stimulatory molecules such as ICOS, regulatory T cell
108              Therefore, we hypothesized that co-stimulatory molecules that preferentially bind CD28 o
109 equires signals from the T cell receptor and co-stimulatory molecules to license effector functions o
110 he allograft response, and blocking positive co-stimulatory molecules with active delivery of inhibit
111 in a multi-step process involving cytokines, co-stimulatory molecules, and a variety of antigen-prese
112 ires signals from the T cell receptor (TCR), co-stimulatory molecules, and cytokines.
113 ules, including the T-cell receptor complex, co-stimulatory molecules, and integrins unrelated to LFA
114 s to attenuate T cell activation via TCR and co-stimulatory molecules, and its reduction during T cel
115 s, regulation of MHC expression, activity of co-stimulatory molecules, and the signalling cascades ac
116 t sizes, the use of adjuvants, cytokines and co-stimulatory molecules, epitope enhancement and the st
117 ich are members of the extended B7 family of co-stimulatory molecules, have diverse functions in the
118 ity in function, which is not seen for other co-stimulatory molecules, is responsible for the unique
119 ption factors, c-Maf and NFIL3, and negative co-stimulatory molecules, LAG-3, TIGIT, PD-1 and TIM-3,
120 ure and process antigens, express lymphocyte co-stimulatory molecules, migrate to lymphoid organs and
121  during viral infections, by manipulation of co-stimulatory molecules, or in the development of tumor
122  associated with higher expression levels of co-stimulatory molecules, PD-L1, IL-6, TNF-alpha, and IL
123 synapse', including integrins, cadherins and co-stimulatory molecules, reveal in detail the molecular
124 ed with lipopolysaccharide do not upregulate co-stimulatory molecules, secrete greatly diminished amo
125   In contrast to wild-type CD80, the evolved co-stimulatory molecules, termed CD28-binding protein (C
126 on of relevant peptide epitopes, addition of co-stimulatory molecules, the development of novel vehic
127  class II family, cytokines, chemokines, and co-stimulatory molecules, was significantly altered in t
128 f dendritic cell (DC) maturation markers and co-stimulatory molecules.
129 tory cytokines, as well as adhesion cell and co-stimulatory molecules.
130 -inducible expression of CD40, CD80 and CD86 co-stimulatory molecules.
131 le vaccines together with antibodies against co-stimulatory molecules.
132 ajor histocompatibility complex antigens and co-stimulatory molecules.
133 ivation and immune function are regulated by co-stimulatory molecules.
134 istocompatibility complex (MHC) class II and co-stimulatory molecules.
135 mune responses by differential expression of co-stimulatory molecules.
136 vels of major histocompatibility complex and co-stimulatory molecules.
137 s is associated with increased expression of co-stimulatory molecules.
138 igh expression of PD-L1 and PD-L2 as well as co-stimulatory molecules.
139 sion of major histocompatibility complex and co-stimulatory molecules.
140 wn to engage intraepithelial T cells through co-stimulatory molecules.
141       Activated DCs expressed high levels of co-stimulatory molecules; released inflammatory cytokine
142 the MHC; they are structurally related to B7-co-stimulatory molecules; they are functionally implicat
143  of B lymphocytes, dysregulated cytokine and co-stimulatory networks, infection with potentially onco
144 studies identify a previously unknown T-cell co-stimulatory pathway as a potential therapeutic target
145 with CD28 and constitute an essential T-cell co-stimulatory pathway in the initiation of antigen-spec
146  CD40-CD154 (CD40 ligand) interaction in the co-stimulatory pathway is involved in many (auto)immune
147                                     The CD28 co-stimulatory pathway is well established for T cell ac
148           Here, we demonstrate that the CD28 co-stimulatory pathway regulates the trafficking of self
149 LS mouse model, we identified a role for the co-stimulatory pathway, a key regulator of immune respon
150 ce to study the impact of targeting a T cell-co-stimulatory pathway, and demonstrate that targeting T
151  approaches for targeting B-cell subsets and co-stimulatory pathways are described here in detail.
152 cal CD28 and the non-canonical SLAMF3/SLAMF6 co-stimulatory pathways cooperate in the recruitment of
153 and that crosstalk between co-inhibitory and co-stimulatory pathways in pathogen-specific CD4 T cells
154 ocyte activation can be targeted by blocking co-stimulatory pathways or inhibiting major histocompati
155               Using either agents that block co-stimulatory pathways or the immunosuppressive drug ra
156 e decreasing FVIII uptake by APCs, modifying co-stimulatory pathways, inducing regulatory T-cell prod
157 -/- mice suggest the existence of additional co-stimulatory pathways.
158 ), in the presence of B7- and CD40-dependent co-stimulatory pathways.
159 ith the desensitization of the TRAF1-binding co-stimulatory receptor 4-1BB, 4-1BBL-deficient mice hav
160 ning, we identified an immune cell-specific, co-stimulatory receptor B7.2 (CD86) as a co-receptor of
161                 Interestingly, targeting the co-stimulatory receptor CD137 with an agonistic antibody
162  immunoglobulin and ITIM domain (TIGIT), the co-stimulatory receptor CD226 and their ligand PVR are a
163             TIGIT and CD96 together with the co-stimulatory receptor CD226 form a pathway that is ana
164 l factors such as CD80 and CD86, ligands for co-stimulatory receptor CD28, and interleukin 2 are requ
165 n species (ROS), in a manner mediated by the co-stimulatory receptor CD40.
166                                    OX40 is a co-stimulatory receptor expressed on activated T cells.
167 ) iDCs have lower basal GSH levels, enhanced co-stimulatory receptor expression, impaired phagocytic
168 ies and to regulate pathways that control DC co-stimulatory receptor expression.
169 sis and has been implicated in modulating DC co-stimulatory receptor expression.
170                                              Co-stimulatory receptor gene expression is regulated by
171 e depends on continued signaling through the co-stimulatory receptor ICOS (inducible co-stimulator).
172 lymphocyte activation molecule (Slamf)1 is a co-stimulatory receptor on T cells and regulates cytokin
173  (CTX) and an agonist antibody targeting the co-stimulatory receptor OX40 (OX86) provides potent anti
174 d rodents exhibit atypical expression of the co-stimulatory receptor OX40 on CD4 T cells and that the
175 cal inhibitors, we demonstrate that enhanced co-stimulatory receptor phenotype of Nrf2(-/-) iDC does
176 V and HIV-1 Nefs down-modulate CD28, a major co-stimulatory receptor that mediates effective T-cell a
177                                CD28, a major co-stimulatory receptor, is responsible for the optimal
178 ytokine production suggests NTB-A is a novel co-stimulatory receptor.
179 ing cascades that integrate information from co-stimulatory receptors and locally available cytokines
180 Immature DCs (iDCs) expressing low levels of co-stimulatory receptors are highly efficient at antigen
181 es of the cytoplasmic tails of integrins and co-stimulatory receptors in complex with intracellular s
182 imulation of the T cell receptor complex and co-stimulatory receptors is associated with acute tyrosi
183 ranscription factor NF-kappaB to antigen and co-stimulatory receptors is required for the temporal co
184              Modulation of co-inhibitory and co-stimulatory receptors of the immune system has become
185 munity, upregulates the expression of T-cell co-stimulatory receptors, with the inducible co-stimulat
186 zes recent progress on different features of co-stimulatory regulation and chemokine-mediated homing
187 d in the T-cell receptor signal strength and co-stimulatory requirements needed for their generation.
188 cells are cycling but are defective in their co-stimulatory response when stimulated.
189                                    Given the co-stimulatory role of natural-killer group 2, member D
190 d thus far produce either an activation or a co-stimulatory signal alone, thus limiting the spectrum
191                     TNFSF4 produces a potent co-stimulatory signal for activated CD4+ T cells after e
192 sponse to antigenic challenge by providing a co-stimulatory signal for TCR.
193    To be fully active, immune T cells need a co-stimulatory signal in addition to the main antigen-dr
194 lexes (ICs) in human CD4(+) T-cells produced co-stimulatory signal like CD28 that triggered IFN-gamma
195                                          The co-stimulatory signal promotes T-cell proliferation, lym
196 B7-2 on antigen-presenting cells deliver the co-stimulatory signal through CD28 and CTLA-4 on T cells
197 4(+) T-cells phosphorylate Syk and provide a co-stimulatory signal to CD4(+) T-cells in the absence o
198  cell activation receptor that can provide a co-stimulatory signal to other activation receptors and
199 er338 through PI 3-kinase and Pak provides a co-stimulatory signal which together with Ras leads to s
200 onses require both an antigen-specific and a co-stimulatory signal.
201 ire an antigen-specific signal and a second, co-stimulatory, signal for optimal T-cell activation.
202 hways suggested LGMD2B-specific increases in co-stimulatory signaling between dendritic cells and T c
203 sing on the role of antigen presentation and co-stimulatory signaling pathways in cancer immunology.
204 ch to this problem is to manipulate specific co-stimulatory signaling pathways to enhance CD8(+) effe
205 in sIBM there is upregulation of ICOS.ICOS-L co-stimulatory signalling in association with enhanced p
206 keletal engagement, which is permissive, and co-stimulatory signals (calcium or protein kinase C) gen
207 et, which are dependent on the antigen dose, co-stimulatory signals and the cytokine environment, cri
208  in human cells, promoting the expression of co-stimulatory signals and the secretion of pro-inflamma
209                                      Because co-stimulatory signals are critical for regulating T-cel
210 tical framework for clinical trials in which co-stimulatory signals are manipulated in an attempt to
211  cells are dependent on accessory cell-bound co-stimulatory signals for activation.
212 f the TNFR family known to provide essential co-stimulatory signals for T cell growth and B cell Ig s
213 es the pre-TCR, beta-selection also requires co-stimulatory signals from Notch receptors - key cell f
214 ctivation by NFAT without the cooperation of co-stimulatory signals in lymphocytes can also impose a
215 nced network of positive and negative T-cell co-stimulatory signals is important in regulating T-cell
216                  TLR-inducible expression of co-stimulatory signals is one of the mechanisms of self/
217 ating T-cell activation, an understanding of co-stimulatory signals may enable the design of rational
218 ar and can present antigen in the context of co-stimulatory signals required for the stimulation of b
219 r whether or how the inducible expression of co-stimulatory signals would distinguish between self an
220 ative signals concurrent with blocking CD154 co-stimulatory signals would facilitate islet allograft
221 was enhanced by concurrent blockade of CD154 co-stimulatory signals, as demonstrated by T-cell prolif
222     Here, we propose that the integration of co-stimulatory signals, which regulate the ability of pr
223 and(s) on T cells, thereby delivering T cell co-stimulatory signals.
224  TNF-alpha and suppressing the expression of co-stimulatory surface markers CD80 and CD86.
225 T-cell receptor (TCR) and the CD28 and 4-1BB co-stimulatory surface molecules.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top